Funds Holding Boston Scientific, Inc.

 
Fund Quotes for Funds Holding Boston Scientific, Inc. top ^
  • Holdings: Medtronic Inc , Boston Scientific Inc , Covidien PLC , Abbott Laboratories , Zimmer Holdings Inc ,
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for fsmex investment picks
  • Holdings: Willis Group Holdings PLC , Hub Group Inc Class A , Boston Scientific Inc , Cimarex Energy Co , Brown & Brown Inc ,
  • Category: Mid-Cap Value
  • Morningstar Rating: 3 Stars
Sign-up for dhmyx investment picks
  • Holdings: Willis Group Holdings PLC , Hub Group Inc Class A , Boston Scientific Inc , Cimarex Energy Co , Brown & Brown Inc ,
  • Category: Mid-Cap Value
  • Morningstar Rating: 3 Stars
Sign-up for dhmax investment picks
  • Holdings: Willis Group Holdings PLC , Hub Group Inc Class A , Boston Scientific Inc , Cimarex Energy Co , Brown & Brown Inc ,
  • Category: Mid-Cap Value
  • Morningstar Rating: 3 Stars
Sign-up for dhmcx investment picks
  • Holdings: Willis Group Holdings PLC , Hub Group Inc Class A , Boston Scientific Inc , Cimarex Energy Co , Brown & Brown Inc ,
  • Category: Mid-Cap Value
  • Morningstar Rating: 4 Stars
Sign-up for dhmix investment picks
  • Holdings: Willis Group Holdings PLC , Hub Group Inc Class A , Boston Scientific Inc , Cimarex Energy Co , Brown & Brown Inc ,
  • Category: Mid-Cap Value
  • Morningstar Rating: 3 Stars
Sign-up for dhmax investment picks

 
Stock Quotes for Boston Scientific, Inc. top ^
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
  • Morningstar Rating: 3 Stars
Sign-up for bsx investment picks

 
News Articles for Boston Scientific, Inc. top ^
Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life MARLBOROUGH, Mass.
Sign-up for Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor investment picks
A jury verdict worth $308 million went against Boston Scientific Corp.
Sign-up for Boston Scientific hit with $308 million judgment in royalty dispute investment picks
Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval MARLBOROUGH, Mass.
Sign-up for Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System investment picks
The innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems MARLBOROUGH, Mass.
Sign-up for Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging investment picks
First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease MARLBOROUGH, Mass.
Sign-up for Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific Announces Results For Third Quarter Ended September 30, 2014 investment picks
World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients with Chronic Pain MARLBOROUGH, Mass.
Sign-up for Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge™ Surgical Leads For The Precision Spectra™ Spinal Cord Stimulator (SCS) System investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific To Participate In 2014 Stifel Healthcare Conference investment picks
Event will be held in Chicago, Site of the 2014 American Heart Association Scientific Sessions MARLBOROUGH, Mass.
Sign-up for Boston Scientific To Host And Webcast Investor Event investment picks
Data Will Focus on Long-Term Back Pain Relief Using the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System and Highlight Research on Stimulation Waveforms MARLBOROUGH, Mass.
Sign-up for Boston Scientific Announces Schedule For Presentations At The Upcoming North American Neuromodulation Society (NANS) Meeting investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific Earns Top Marks In Corporate Equality Index investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Boston Scientific, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Boston Properties Inc  |  Next: Funds Holding Bottomline Technologies, Inc.